Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer

Genes and Development - Tập 25 Số 23 - Trang 2465-2479 - 2011
Tanaya Shree1, Oakley C. Olson, Benelita T. Elie, Jemila C. Kester, Alfred L. Garfall, Kenishana Simpson, Katherine M. Bell‐McGuinn, Emily C. Zabor, Edi Brogi, Johanna A. Joyce
1Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA

Tóm tắt

The microenvironment is known to critically modulate tumor progression, yet its role in regulating treatment response is poorly understood. Here we found increased macrophage infiltration and cathepsin protease levels in mammary tumors following paclitaxel (Taxol) chemotherapy. Cathepsin-expressing macrophages protected against Taxol-induced tumor cell death in coculture, an effect fully reversed by cathepsin inhibition and mediated partially by cathepsins B and S. Macrophages were also found to protect against tumor cell death induced by additional chemotherapeutics, specifically etoposide and doxorubicin. Combining Taxol with cathepsin inhibition in vivo significantly enhanced efficacy against primary and metastatic tumors, supporting the therapeutic relevance of this effect. Additionally incorporating continuous low-dose cyclophosphamide dramatically impaired tumor growth and metastasis and improved survival. This study highlights the importance of integrated targeting of the tumor and its microenvironment and implicates macrophages and cathepsins in blunting chemotherapeutic response.

Từ khóa


Tài liệu tham khảo

10.1074/jbc.M801327200

10.1073/pnas.0911378107

10.1158/0008-5472.CAN-07-0602

10.1158/1078-0432.CCR-07-1562

10.1016/S1074-5521(00)00061-2

10.1007/s10585-005-2908-5

1974, Tissue culture studies on pleural effusions from breast carcinoma patients, Cancer Res, 34, 801

2011, Leukocyte complexity in breast cancer predicts overall survival and functionally regulates response to chemotherapy, Cancer Discov, 1, 52

10.1158/0008-5472.CAN-04-0580

10.1101/gad.1407406

10.1515/BC.2010.080

10.1101/gad.1874010

10.1016/S1074-5521(00)00014-4

1992, Induction of mammary tumors by expression of polyomavirus middle T oncogene: A transgenic mouse model for metastatic disease, Mol Cell Biol, 12, 954

10.1172/JCI9411

10.1038/nrc2618

10.1016/S1535-6108(04)00111-4

10.1038/nrc1369

10.1007/s00441-007-0474-7

10.1158/0008-5472.CAN-09-4446

10.1016/S0002-9440(10)63568-7

10.1111/j.1749-6632.2010.05763.x

2002, Antitumor effects in mice of low-dose (metronomic) cyclophosphamide administered continuously through the drinking water, Cancer Res, 62, 2731

10.1038/nrc1949

10.2174/156800906776056473

10.1016/j.tips.2007.10.011

10.1073/pnas.96.15.8627

10.1200/JCO.2005.07.093

10.1007/s00259-003-1441-5

Pyonteck SM , Gadea BB , Wang HW , Gocheva V , Hunter KE , Tang LH , Joyce JA . 2011. Deficiency of the macrophage growth factor CSF-1 disrupts pancreatic neuroendocrine tumor development. Oncogene doi: 10.1038/onc.2011.337.

10.1016/j.cell.2010.03.014

10.1172/JCI42918

10.1096/fj.99-0970com

10.1586/14737140.8.12.1907

10.1515/BC.2008.115

10.1073/pnas.0907240107

10.1016/j.ccr.2008.08.001

10.1023/A:1018994111594

10.1016/S1074-7613(00)80020-5

10.4049/jimmunol.179.5.2851

10.1172/JCI25705

10.1038/clpt.2010.96